There is a resurgence of interest in the study of occurrence, genotype and pathogenic associations of human Polyomaviruses in recent years. In the present study, we have ascertained the presence of human Polyomavirus JC (JCV) in the urine and peripheral blood leukocytes of tribal populations, for the first time in the North-Eastern part of West Bengal State of India. We have also characterized the prevalent genotypes of the non-coding control regions (NCCRs) of these natural isolates. The result suggests a high incidence of JCV reactivation in the populations assayed. Approximately 25% of the non-immunocompromized tribal men and women, tested positive based on polymerase chain reaction (PCR) analysis, and these results were further confirmed by sequencing of PCR products. Pairwise sequence comparison and alignment of the NCCR sequence of these Indian strains appeared to be comparable and related to the archetypal JCV (CY) and the Tibetan LH3 strains, with some alterations in few key positions. The sequence analyses were done with regard to transcription factor binding to DNA sequence elements of endemic JCV NCCRs.
Introduction
JC virus (JCV), a member of the Polyomaviridae family, was first isolated from brain tissue of a 38 year old man with initials -JC, who was suffering from Hodgkin's disease for a quite a long time (Padgett et al., 1971) . JC virus has simple genome containing a single molecule of covalently closed, circular double-stranded DNA of about 5000 base pair in length (Frisque et al., 1984) . The viral genome comprises early and late coding regions that are controlled by a common Non-Coding Control Region (NCCR), which lies between them. The early proximal side of the NCCR is highly conserved and contains the origin of viral DNA replication. The late proximal side of the NCCR contains the repetitive enhancer elements and undergoes rearrangements that account for most of the differences between different strains of the same virus.
Transcriptional regulation of the JCV early and late promoters during the viral lytic cycle is a complicated event that requires participation of both viral key proteins and cellular transcription factors. Several transcription factors are implicated in the regulation of JCV gene expression which include NF-κB (Ranganathan and , NFAT4 (Wollebo et al., 2012) , upstream Target or up-TAR (Chowdhury et al., 1993) , Tst-1 (Wegner et al., 1993) , Sp-1 (Henson et al., 1992) , Spi-B (Marshall et al., 2010) , GBP-i (Raj and Khalili, 1994) , Y-box binding protein 1 (YB-1) and Purα (Chen and Khalili, 1995) , Nuclear factor 1 or NF-1 (Amemiya et al. 1989) , CREB/ATF-1 (Lonze and Guinty, 2002) , Activator Protein 1 (AP-1) family members (Sadowska et al., 2003) , p53 (Ariza et al., 1994) , Early growth response-1 protein or Egr-1 (Romagnoli et al., 2008) , Bcl-2-associated athano gene-1 or BAG-1 (Devireddy et al., 2000) and CAAT/enhancer binding protein beta or C/EBPβ (Romagnoli et al., 2009) .
JC polyomavirus is widespread in the human population and causes a rare fatal brain infection known as Progressive Multifocal Leucoencephalopathy (PML). PML occurs mainly in a limited number of individuals with suppressed immune system, especially in those with Human Immunodeficiency Virus (HIV) infection/ AIDS (Hou and Major, 2000; Khalili et al., 2006) and involves productive infection in both oligodendrocytes and astrocytes. However, there are reports where
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Tribal Populations of North-Eastern West Bengal, India 2 192 researchers have shown that JCV can even induce PML in non-immunocompromised individuals without AIDS, such as patients receiving monoclonal antibody natalizumab (Langer-Gould et al., 2009) . JCV exists in ten or more geographically based genotypes identified in the United States, Africa, Europe and Asia (Agostini et al., 1997; Sugimoto et al., 2002) . There appear to be several Asian subtypes and the Indian subtype has been designated as Type 2D (Cui et al., 2004) .
In this study, we have screened urine and blood samples from tribal/ethnic human population of northeastern part of West Bengal state of India to record for the first time the JCV reactivation status and to ascertain the prevalent nature of endemic viral NCCRs. Specific oligonucleotide primers were used to amplify the JCV NCCRs by PCR and then sequenced to analyze their genetic architectures. We have recorded about 25% of the subjects to be positive for JCV NCCRs. Analyses of predicted transcription factor binding sites (TFBS) revealed additional putative promoter elements in endemic NCCRs capable of binding to a diverse set of human/vertebrate transcription factors. Further in vivo and in vitro experiments are expected to substantiate these findings.
Experimental

Materials and Methods
Sample collection. The study methodology was approved by our institutional Human Ethical Committee. A total of 77 samples were collected from the tribal, non-immunosuppressed populations of the north-eastern part of West Bengal State of India with their prior informed consent. The samples included either urine or blood specimens from each individual. The collected samples were from two tribal groups of North Bengal -Oraon and Mundas of Kiran Chandra tea garden, Naxalbari, Darjeeling district (26°41'N Lat; 88°16'E Long) and Rabha or Rava population of Poro Busty, Tufanganj, Coochbehar district (26°18'N Lat; 89°39'E Long). The urine samples were collected in 1.5 ml eppendorf tubes and about 1 ml of blood samples were collected in vials containing EDTA. All the samples were brought to the laboratory and stored at -20°C refrigerator prior to DNA isolation. DNA Isolation. DNA isolation from urine and blood samples was done using the High Pure Viral Nucleic Acid Kit (Roche Diagnostic GmbH, Germany) as per the manufacturer's instruction. In brief, 200 µl of freshly prepared working solution (carrier RNAsupplemented binding buffer) and 50 µl of Proteinase K solution was added to 200 µl of sample and incubated at 72°C for 10 minutes. Then 100 µl of binding buffer was added and centrifuged at 8,000 × g for 1min. The flowthrough liquid was discarded and 500 µl of inhibitor removal buffer was added and centrifuged again at 8,000 × g for 1 min. After discarding the flow through, samples were washed twice with 450 µl wash buffer. The last step included addition of 50 µl elution buffer followed by centrifugation at 8,000 × g for 1 min. The isolated DNA samples were stored in -20°C refrigerator until used for PCR amplification.
Standard Viral DNA. Plasmid pMITC-BSMKS containing the whole JCV genome (JCV Mad-1 strain) was a gift from Richard J. Frisque, Department of Biochemistry, Microbiology, Molecular & Cell Biology, Pennsylvania State University, USA. The plasmid pGMTW3JCV containing the whole genome of JCV (JCV Taiwan-3 strain) was gifted by Deching Chang, National Chung Cheng University, Taiwan.
PCR amplification and Electrophoretic analysis of endemic JCV NCCRs. Two oligonucleotide primers namely SDJ1 (5'-CCCTATTCAGCACTTTGTCC-3') and SDJ2 (5'-CAAACCACTGTGTCTCTGTC-3') were used for the amplification of the viral control region DNA. A final volume 50 µl PCR reaction mixture contained 20 pM of each primer, 200 µM dNTPs (NEB, USA), 10X standard Taq buffer containing MgCl 2 (NEB, USA) and Taq Polymerase enzyme (NEB, USA). Twenty microlitres of isolated DNA was used for each PCR amplification reaction. Amplifications were performed in an Applied Biosystems Thermal Cycler (Model: 2720 Thermal Cycler, Life Technologies, USA) programmed for initial heating at 94°C for 5 min, 25 cycles at 94°C for 1 min, annealing at 56°C for 1 min, and extension at 72°C for 1 min. A final extension was performed at 72°C for 5 min. The cloned JCV genome plasmids pMITC-BSMKS or pGMTW3JCV were used as positive control in each reaction and sterile distilled water was used as negative control. PCR products were run on 1% agarose gel containing 0.5 µg/ml of Ethidium bromide at 80 V for 1 hour approximately in a Bench Top Lab Systems (Model: BT-MS-300, Taiwan) electrophoresis apparatus and then visualized in a UV transilluminator (Spectroline BI-O-Vision UV/White Light Transilluminator, NY, USA).
Sequence Analysis. Sequencing of the JC virus NCCR PCR product from each positive sample was done at least twice by dye-dideoxy automated chain termination method (Biolinkk, New Delhi, India) and only six of them were deposited in NCBI public domain for GenBank accession. All the remaining NCCR sequences were similar to the ones deposited for GenBank accession. Submission IDs are as follows: NB1 (JX294575), NB2 (JX534216), NB3 (JX534217), NB4 (JX534218), NB5 (JX534219) and NB6 (JX534220). Nucleotide sequences of the endemic JCV NCCRs were aligned with the known NCCR sequences of JCV 2 193 strains CY, LH3, Tai3, IN-8 and Mad-1 using DiAlign alignment program of Genomatix suite v2.5 GmbH (Cartharius et al., 2005) to compare pairwise similarities (relative to the maximum similarity) among these sequences. All NCCR sequences (T-antigen coding start site to Agnogene coding start site) were again aligned in ClustalX ver. 2.0.3 (Thompson et al., 1997) using default parameters, curated in BioEdit ver. 7.0.9.0 (Hall, 1999) to generate an alignment showing deletion/mutation and common transcription factor binding sites derived from experimental data of other research groups. The NCCR sequences of NB3, 4 and 5 being identical only NB3 was included in the multiple sequence alignment. The MatInspector program of Genomatix Software suite v2.5 GmbH (Cartharius et al., 2005) was used to search for the predicted transcription factor binding sites (TFBS) in the aligned portion of endemic using a large library of weight matrices based on general core promoter and vertebrate promoter matrix families.
Results
PCR amplification and Electrophoretic analyses.
PCR amplification of JCV specific NCCR from all urine as well as from blood samples was done to check the prevalence of the virus in the North Bengal region of India. Seventy-seven samples of urine and blood were collected from the tribal, non immunosuppressed populations of this region. Twenty-four samples were from Kiran Chandra tea garden, Naxalbari, Darjeeling district and 53 samples were collected from Poro busty, Tufangunj, Coochbehar district of West Bengal. The two primers SDJ1 and SDJ2 specific for NCCR region amplified a product of approximately 586 bp of DNA. After PCR amplification, products were analysed by agarose gel electrophoresis (Fig. 1 ). Seven out of 24 assayable samples from the Oraon and Munda tribal groups in Kiran Chandra tea garden were found to be JCV positive showing an overall incidence of 29.17%. In Poro busty, Tufangunj, having mostly Rabha tribal population, 12 out of 53 samples supported positive amplification of the JCV NCCR region having an overall incidence of 22.64% (Table I) . Thus the overall incidence of JCV control region DNA in urine and blood of non-immunosuppressed general tribal population was found to be 24.67% (19 out of 77 individuals) in this north-eastern part of India.
Pairwise Comparison of endemic JCV NCCRs with strains reported from North-East and South-East Asia. NCCR region is the variable segment of the viral genome except the early proximal part of the sequence which is highly conserved. In this study, DiAlign program of the Genomatix software suite (Table II) Chattaraj S. and Bhattacharjee S.
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Mad-1 strains. It was evident from the study that the NCCR sequences of NB3, 4 and 5 were identical. All the NCCR sequences (NB1-5) except the NB6 paired closely with each other (98-100% similar). Pairwise sequence comparison with other strains revealed that the NCCR sequence of NB1, 2, 3, 4 and 5 were almost similar to the Tibetan LH3 (97-98% similar) NCCR sequence and the NB6 NCCR sequence seemed almost identical with CY strain (98% similarity). These NCCR sequences including that of NB6 were divergent from Tai3, IN-8 and as expected from Mad-1 control regions.
Analyses of NCCRs for Transcription Factor Binding Sites (TFBS).
Multiple sequence alignment of endemic JCV NCCRs and other strains reported earlier revealed a 10 nucleotide (169-178) and a di-nucleotide (454-455) deletions in NB1, 2, and 3 (and also in NB5 and NB6) but not in NB6 (Fig. 2 ). Point mutations in seven different sites within the NCCR of the endemic strains recorded are at 4, 13, 26, 27, 69, 226 and 452 nucleotide positions of the sequence alignment (Fig. 2) .
Several transactivating factors have been experimentally shown to bind to JCV NCCR either individually or cooperatively with other cellular factors and/or virus encoded proteins. The binding motifs of NF-κB, NFAT4, upstream Target or up-TAR, Tst-1, Sp-1, Spi-B, GBP-i, Y-box binding protein 1, Purα, Nuclear factor 1 or NF-1, CREB/ATF-1, Activator Protein 1 (AP-1) family members, p53, Early growth response-1 protein or Egr-1, Bcl-2-associated athano gene-1 or BAG-1 and CAAT/enhancer binding protein beta or C/EBPβ are shown on the aligned sequences (Fig. 2) . In an effort to check further the binding of putative transcription factors to this control region in silico we have searched a well defined general core and vertebrate transcription factor matrix families in MatInspector program of the Genomatix software suite (Cartharius et al., 2005) . Supplementary Table I shows putative binding sites of transcription factors in an abridged form. Matches for transcription factors that are reported to be active in cells/tissues such as antibody-producing cells, antigenpresenting cells, bone marrow cells, hematopoietic and immune system, leukocytes, lymphocytes, monocytes, myeloid cells, phagocytes, brain, CNS, endocrine system, kidney, nervous system, urinogenital system are retained in the table list.
Discussion
We report here, for the first time, the incidence and sequence characterization of human polyomavirus JCV non-coding control/regulatory regions or NCCRs, Chattaraj S. and Bhattacharjee S.
2 196 amplified directly from urine and blood samples of non-immunocompromized healthy tribal groups from north-eastern parts of West Bengal State of India. The objectives of the current investigation were (1) to document the prevalence or reactivation status of human polyomavirus JCV in non-immunosuppressed Indian tribal population, (2) to compare and contrast intergenic NCCR motifs of JCV variants found in healthy subjects with respect to transcription/transactivating factor binding and (3) to predict putative transcription factor binding sites within the endemic NCCR variants.
Initial infection with human polyomavirus seems to occur through the oral/respiratory route in childhood, as evidenced by detection of JCV DNA in infant tonsillar tissues, after which they remain in latent state in organs like kidneys, hematopoietic precursor cells, B-lymphocytes etc. till reactivation (Boldorini et al., 2003; Dorries et al., 1994; Monaco et al., 1998) . Reactivation of both BKV and JCV infection with resulting urinary excretion of viruses readily occurs during conditions of immune suppression or immunocompromization. Conventional PCR has been used to detect and characterize both BKV and JCV DNA in urine of different patient groups, from different human tissues and from urine of pregnant women (Arthur et al., 1989; Markowitz et al., 1991) . Regulatory regions of both BKV and JCV have been amplified and characterized from urine of bone marrow and renal transplant patients, HIV positive or negative individuals, patients with various autoimmune diseases. Full-length JCV genomes or DNA sequences have also been isolated and characterized from normal brain tissue, new born infants, immunocompetent older individuals and peripheral blood leucocytes of immunocompetent individuals (Kitamura et al., 1990; Elsner and Dorries, 1992, Dorries et al., 1994; Baksh et al., 2001) .
Detection of JCV nucleic acid in urine (Tan et al., 2009; Husseiny et al., 2010) , brain autopsy and CNS tissues (Delbue et al., 2008) ; serum/peripheral blood leukocytes (PBL) (Gu et al., 2003; Tan et al., 2009; Husseiny et al., 2010) , bone marrow aspirates (Tan et al., 2009) of normal or non-immunocompromized human subjects, in different age groups, have been reported from many regions of the world. The JCV DNA occurrence in all these studies ranged from 0 to 20% based on variable sample sizes. Incidences of JCV viruria in different tribal populations showed variations with respect to the groups studied: 56 to 66% in Native Americans (Agostini et al., 1997) , 48 to 67% in Myanmar tribals (Saruwatari et al., 2002) and 20 to 22% in African tribals (Chima et al., 1998) . We have recorded a relatively high incidence of JCV DNA detection in non-immunosuppressed and healthy human tribal groups in our study (Table I) . Out of 77 assayable urine and blood samples 19 (~25 %) were scored positive by gel electrophoresis and PCR product sequencing, and 58 (~75%) samples were scored negative based on the above mentioned criteria.
The non-coding control regions (NCCRs) of JC virus vary considerably among different natural isolates. Archetype like DNA, which lacks sequence repeats in the regulatory region and contains additional sequences, are generally not found in laboratory strains, but has been isolated by molecular cloning from several sources. Rearrangement of NCCRs occurs during passage in cell culture more readily. During reactivation in pregnancy, the shed viruses show archetype-like sequence rearrangement in their NCCRs (Markowitz et al., 1991; Markowitz et al., 1993) . Viral strains with divergent NCCRs may have different tissue tropism and also aberrant potential for host cell transformation (Sundsfjord et al., 1994) . It has been postulated that the rearrangement in the NCCRs may change the biological properties of polyomaviruses in the due course of a persistent infection, such as the ability to infect different target cells. Reactivation of BKV and/ or JCV infection, with the resultant urinary excretion of virus, may occur in healthy individuals but occurs more frequently under conditions of immunosuppression, especially when T-cell functions are depressed (Chesters et al., 1983; Gardner et al., 1984) . JCV infection has been demostrated in B-lymphocytes (Dorries et al., 1994) and JCV specific CD4 + T-lymphocytes have been reported in healthy individuals (Gasnault et al., 2003) . Healthy individuals have also been shown to harbour JCV-specific CD8 + T-Lymphocytes, principally against VP1 p36 epitopes, in their peripheral blood mononuclear cells (Du Pasquier et al., 2004) . Fragments of JCV DNA, but not proteins, have been detected in multiple regions of non-immunocompromized and non-PML normal brains (Perez-Liz et al., 2008) . The authors have also hypothesized that JCV could spread within normal brain tissue through blood or infected immune cells like B-lymphocytes and remain as integrated or episomal forms within the oligodendrocytes and astrocytes till its initiation of lytic life cycle during immune impairment. Therefore this model raises the possibility of human brain being a secondary site of latency for JCV.
We have investigated the binding sites of known and reported transcription factors/transactivators in the endemic JCV NCCRs and also used computer software to search for additional transcription factors having potential to bind to this region of JCV genome. Two prominent features within the endemic JCV NCCR Box B are the absence, unlike JCV Mad-1, of full-length Purα/YB-1 binding pentanucleotide (5'-AGGGAAGGGA-3') (Chen and Khalili, 1995) and the presence of Sp1 binding site (GA Box) (5'-AGG-GAGGAGC-3') (Henson et al., 1992) in the same 2 197 (Fig. 2) . In the light of these findings (Chen and Khalili, 1995 ) the significance of partial Purα/YB-1 binding sites within the NCCRs of the endemic circulating JCV vis-a-vis the level of viral T antigen expression within the tissues needs to be validated through cell culture-based gene expression studies. The terminal two nucleotide deletions in the Purα/YB-1 binding pentanucleotide and the concomitant presence of Sp1 binding GA-Box needs to be investigated with respect to glial cell specific gene expression studies. Cellular tumour suppressor protein p53 is reported to bind to JCV large T antigen to repress viral replication (Staib et al., 1996) and/or directly to and regulate JCV promoter (Ariza et al., 1994) . We have found a di-nucleotide deletion within this p53 binding site of endemic JCV strains from Oraon/Munda group but not from the Rabha group (NB6) (Fig. 2) . Implications of this deletion in the NCCRs of JCV NB1 to NB5 need to be evaluated in in vivo studies. The predicted TFBS depicted putative binding sites for transcription factors corresponding to thirty-three matrix families (Supplementary Table I ). We retained the putative TFBS matches which are reported to be active in cells/tissues such as antibody-producing cells, antigen-presenting cells, bone marrow cells, hematopoietic and immune system, leukocytes, lymphocytes, monocytes, myeloid cells, phagocytes, brain, CNS, endocrine system, kidney, nervous system, urinogenital system. Although the TFBS were common to NB1 to NB6, on a closer look we can see few transcription factors (Neuron-specific Olfactory factor or NOLF, p53 tumor suppressor, TALE homeodomain class recognizing TG motifs or TALE, X-box binding factor or XBBF and Activator/repressor binding to transcription initiation site or YY1F) matching exclusively to either positive (+) or negative (-) strands of NB6 NCCR owing to its sequence differences with that of other endemic NCCRs. While the implications of these finding cannot be guessed at this juncture, the list is likely to provide a hint for a detailed in vivo binding studies to validate hypotheses regarding tissue-specific promoter activities in JCV. In summary, we have reported for the first time the NCCR architecture of the endemic JCV strains in tribal population groups from north-eastern region of India and have compared their sequences with that of other key JCV strains from Asia. The NCCR sequence analyses were done with regard to transcription factor binding to DNA sequence elements of endemic JCV NCCRs.
JCV NB1, NB2, NB3, NB6 showed 99, 140, 144, and 155 total matches respectively. JCV NB3, 5 and 6 being identical, only NB3 was included in the search. Matrix similarity column refers to an optimized similarity match above 0.80 score while a perfect match to the matrix is marked by a maximum score of 1.00. All matches below 0.80 score were excluded in the table. A range of scores for discrete sequences are shown where appropriate. Start and end positions of TF binding sites are numbered according to the aligned NCCR sequences as shown in Figure 1 . Matching sequences found in negative strands are indicated as (-); however sequences are numbered along the plus strands. Matching sequences found only in NB6 are indicated within parentheses at the end of the sequences. 
